Skip to content
Dose Brief
Menu
No. 245 on the board · Grade C

GobyMeds review

Affordable telehealth provider offering compounded semaglutide only.

Visit GobyMeds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $99/mo (starting dose, 3-month plan, compounded)
Tirzepatide
From $133/mo (starting dose, 3 month plan, compounded)
Coverage
Coverage not published
Brand-name
Yes
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $99/mo (starting dose, 3-month plan, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

GobyMeds scored on our six Brief Score factors. See the methodology.

Price Stability36/100
Supply Reliability77/100
Transparency72/100
Access Breadth56/100
Clinical Oversight82/100
Track Record73/100

What we like

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The brief

Best for: Readers who want budget-conscious shoppers. Affordable telehealth provider offering compounded semaglutide only.

Ranked #245 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest GobyMeds — the realistic shortlist if you're weighing it.

Weighing GobyMeds against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs GobyMeds, and every desk that outranks it is listed on the GobyMeds alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect GobyMeds's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on GobyMeds's site. Not medical advice; see our disclosure.

← Back to all rankings